SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Despite reporting blockbuster earnings and raising guidance, NVIDIA's stock is experiencing a notable decline, sparking intense community debate over alleged market manipulation and broader AI valuation concerns, even as many investors view this as a prime buying opportunity.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending following a strong Q4 earnings beat, optimistic 2026 revenue guidance, and strategic wins like a new European quantum key distribution network and a spot on the $151 billion SHIELD defense contract, sparking a short squeeze as the community weighs its accelerating growth in quantum infrastructure against profitability concerns.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is trending after a substantial earnings miss and weak guidance led to a significant stock drop, causing widespread community distrust in management, though some investors see it as an oversold opportunity in the growing energy storage sector.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following its recent earnings, which showed a swing to profitability and an improved outlook, supported by a new non-dilutive credit facility. The community is highly focused on the potential for a significant short squeeze given the high short interest and the strategic value of its Matrix-M adjuvant, especially with new oncology-focused partnerships and the Pfizer collaboration.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending as its recent earnings report, featuring a beat on estimates and management's commentary on debt and international growth, triggers intense debate among investors over its perceived extreme undervaluation and the potential for a significant short squeeze.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending as its strong quarterly earnings beat and robust financials clash with a flat stock performance, leading to investor frustration and calls for CEO Peter Greenleaf's removal due to perceived lack of transparency on the AUR200 pipeline, despite continued speculation about a potential buyout or strategic partnership.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

FDA's feedback suggesting uniQure's AMT-130 data is currently insufficient for a Biologics License Application, alongside public comments from FDA Commissioner Marty Makary, has fueled intense debate. The community is sharply divided over whether the market overreacted or if the agency's unpredictable stance creates significant regulatory hurdles for rare disease gene therapies.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is trending amid a sharp sell-off, fueled by market fears that new AI-powered translation services threaten its business model, while a vocal community defends its unique language learning approach and strong fundamentals ahead of its upcoming earnings report.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending following its strong earnings beat, increased dividend, and the announcement of a massive new share repurchase program, which many in the community view as a strong vote of confidence and a major catalyst. However, a cautious future revenue outlook and ongoing concerns about AI's impact on the software sector are fueling debate among investors.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is a hot topic among investors leading up to its earnings next week, driven by strong expectations for its AI semiconductor revenue to double and a significant AI backlog. While many are buying dips, confident in its AI infrastructure leadership and high analyst price targets, others express caution regarding its current valuation amidst broader sector dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Citigroup Inc. Sells 2,390 Shares of Medpace Holdings, Inc. $MEDP

Citigroup Inc. reduced its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 2.4% during the third quarter, according to its most recent 13F filing with the Securities & Exchange...

Vulcan Value Partners LLC Has $103.24 Million Stake in Medpace Holdings, Inc. $MEDP

Vulcan Value Partners LLC lowered its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 30.4% in the third quarter, according to the company in its most recent Form 13F filing with...

Vanguard Group Inc. Sells 107,651 Shares of Medpace Holdings, Inc. $MEDP

Vanguard Group Inc. trimmed its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 4.5% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund...

Skandinaviska Enskilda Banken AB publ Has $3.86 Million Position in Medpace Holdings, Inc. $MEDP

Skandinaviska Enskilda Banken AB publ lowered its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 87.3% in the third quarter, according to its most recent Form 13F filing with the...

Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility

Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge...

Rep. Gilbert Ray Cisneros, Jr. Sells Medpace Holdings, Inc. (NASDAQ:MEDP) Shares

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Medpace Holdings, Inc. (NASDAQ:MEDP). In a filing disclosed on February 13th, the Representative disclosed that they...

Pallas Capital Advisors LLC Increases Position in Medpace Holdings, Inc. $MEDP

Pallas Capital Advisors LLC lifted its position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 154.1% during the third quarter, according to the company in its most recent filing...

Medpace Holdings, Inc. (NASDAQ:MEDP) Given Consensus Rating of "Hold" by Analysts

Shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Get Free Report) have earned a consensus recommendation of "Hold" from the fourteen brokerages that are covering the company, Marketbeat Ratings...

Medpace Holdings, Inc. $MEDP Shares Sold by Rhumbline Advisers

Rhumbline Advisers trimmed its stake in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 5.8% during the third quarter, according to its most recent filing with the Securities and...

Cibc World Market Inc. Makes New $5.03 Million Investment in Medpace Holdings, Inc. $MEDP

Cibc World Market Inc. acquired a new position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the...

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Current Price	$447.31
Prev Close	$438.08
Open	$440.54
Dividend Yield	0.00%
50-Day Moving Average	$550.22
Beta	1.13
Avg. Volume	211,748.75
PE Ratio	28.65

52-Week High	$628.92
52-Week Low	$250.05
Market Capitalization	$12.46B
EPS (Annual)	$15.28
Price to Book	27.01
Revenue Per Employee	$408,102.26

MEDP
Medpace Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MEDP News

MEDPMedpace Holdings Inc